NCT02065154
- Conditions
- Allogeneic Transplant, Anemia, Anemia, Aplastic, +31 more
- Locations
-
- UAB Bone Marrow Transplantation and Cellular Therapy Program Birmingham, Alabama, United States
Clinical trial condition
Leukemia, Myeloid
Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.
3,108 public trials
620 recruiting studies
Leukemia, Myeloid trial results
Completed
A Sequential Two-Stage Dose Escalation Study to Evaluate the Safety and Efficacy of Ruxolitinib
NCT01776723
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Conditions
- Bone Marrow Diseases, Chronic Disease, Disease Attributes, +12 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Greenville Health System Little Rock, Arkansas, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Compassionate Cancer Care Medical Group Incorporated Riverside, California, United States
NCT05541224
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Hospital General Universitario de Albacete Albacete, Spain
- Hospital General Universitario de Alicante Alicante, Spain
- Hospital Germans Trias i Pujol-ICO Badalona, Spain
- Hospital Universitario de Burgos Burgos, Spain
Completed
Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
NCT01555268
- Conditions
- Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), +28 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
- University of Rochester Rochester, New York, United States
NCT02582359
- Conditions
- Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Blood Protein Disorders, +23 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
- Conditions
- Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, +34 more
- Locations
-
- Beebe Medical Center Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
- AdventHealth Orlando Orlando, Florida, United States
- University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States
Completed
Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
NCT01253070
- Conditions
- Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +12 more
- Locations
-
- Beebe Medical Center Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital Newark, Delaware, United States
- AdventHealth Orlando Orlando, Florida, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
NCT03723681
- Conditions
- Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China